Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001574017 | SCV001838952 | benign | not provided | 2018-12-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24008425, 28655553, 27884173, 16835894, 16086317, 11702217) |
Ce |
RCV001574017 | SCV002563319 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ABCC6: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV001574017 | SCV005290322 | benign | not provided | criteria provided, single submitter | not provided | ||
PXE International | RCV000499235 | SCV000589022 | benign | Autosomal recessive inherited pseudoxanthoma elasticum | 2021-03-01 | no assertion criteria provided | research | |
Reproductive Health Research and Development, |
RCV000499235 | SCV001142461 | likely benign | Autosomal recessive inherited pseudoxanthoma elasticum | 2020-01-06 | no assertion criteria provided | curation | NG_007558.2(NM_001171.5):c.346-6G>A in the ABCC6 gene has an allele frequency of 0.05 in European (non-Finnish) subpopulation in the gnomAD database. One family with generalized arterial calcification of infancy had compound heterozygous mutations c.346-6G>A and p.R1141 in intron 3 and exon 24 of ABCC6 (PMID24008425). Benign computational verdict because benign prediction from DANN. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BP4, PM3, PP4. |
Laboratory of Diagnostic Genome Analysis, |
RCV001574017 | SCV001800705 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700195 | SCV001918231 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001574017 | SCV001929027 | likely benign | not provided | no assertion criteria provided | clinical testing |